IRONWOOD PHARMACEUTICALS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- IRONWOOD PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2014 was $190.43M, a 38.23% increase from fiscal 2013.
- IRONWOOD PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2013 was $137.77M, a 61.64% increase from fiscal 2012.
- IRONWOOD PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2012 was $85.23M.
- IRONWOOD PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2010 was $203.17M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2014-12-31 | $190.43M 10-K · filed 2017-02-22 | |
| 2013-12-31 | $137.77M 10-K · filed 2016-02-19 | |
| 2012-12-31 | $85.23M 10-K · filed 2015-02-18 | |
| 2010-12-31 | $203.17M 10-K · filed 2013-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |